Evidence map›Paper›PMID 40420644›Full record

ArticleScience progress

Mid-term outcomes of complex TASC D lesions involving the common femoral artery bifurcation.

Yue Lin, Tianyue Pan, Shichai Hong, Weifeng Lu, WeiGuo Fu, LiXin Wang, Xiang Hong, Gang Chen, Yulong Huang, Yihui Chen and 1 more

Abstract read
In one paragraph

Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yue LinDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.ORCID 0000-0002-2309-1529
Tianyue PanDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
Shichai HongDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
Weifeng LuDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.ORCID 0000-0003-4156-5094
WeiGuo FuDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.ORCID 0000-0001-5025-8542
LiXin WangDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.ORCID 0000-0002-1379-3906
Xiang HongDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
Gang ChenDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
Yulong HuangDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.ORCID 0009-0001-9597-7302
Yihui ChenDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
Xinsheng XieDepartment of Vascular Surgery, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveThe aim of this study was to evaluate the efficacy of hybrid therapy and endovascular therapy in the treatment of complex femoropopliteal Trans-Atlantic Inter-Society Consensus II D(TASC D) lesions involving the common femoral artery bifurcation.MethodsPatients with complex femoropopliteal TASC D lesions involving the bifurcation of the common femoral artery for atherosclerotic disease were retrospectively analyzed in our institution from July 2018 to July 2023. Patients were followed up at 1, 3, 6, and 12 months and then every year. Clinical data were collected, including perioperative and follow-up information. The patency rate and the rate of freedom from clinically driven target lesion revascularization (CD-TLR) were measured using the Kaplan-Meier method.ResultsA total of 29 patients with 31 limbs (mean age 73.5 ± 11.5 years; 20 men) were included, divided into the hybrid therapy group (20 limbs, Group 1) and endovascular treatment group (11 limbs, Group 2). The mean follow-up time was 22.5 ± 16.3 months (1-60 months), and the mean length of the lesion was 31.5 ± 11.6 cm. Between these two groups, there was no statistically significant difference on baseline data

Indexed as

Endovascular ProceduresFemoral ArteryPeripheral Arterial DiseaseAgedAged, 80 and overFemaleHumansMaleMiddle AgedPopliteal ArteryRetrospective StudiesTreatment OutcomeVascular Patencycommon femoral artery bifurcationCTOhybrid therapyTASC D lesions

Identifiers

PMID40420644
PMCPMC12117240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.